Aeon Biopharma, Inc.2025财年第一财季实现净利润9.10百万美元,同比增加107.71%

市场透视
23 May

5月23日,Aeon Biopharma, Inc.(AEON.US)公布财报,公告显示公司2025财年第一财季净利润为9.10百万美元,同比增加107.71%;其中营业收入为0.00美元,每股基本收益为2.28美元。从资产负债表来看,Aeon Biopharma, Inc.(AEON.US)总负债25.12百万美元,其中短期债务197000.00美元,资产负债比为0.55,流动比率为1.43。...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10